Atrium Therapeutics
Atrium is seeking a hands-on Scientist I to join the Integrated Discovery and Technical Development Team, focusing on the design, synthesis, purification, characterization, and scale-up of antibody-oligonucleotide conjugates (AOCs) for targeted RNA delivery to cardiomyocytes. This bench-based role involves advancing candidate AOCs from discovery through IND-enabling studies and supporting late-stage development. The position requires collaboration with cross-functional teams to optimize conjugation and purification processes while developing analytical methods for bioconjugate characterization.
Our vision is to pioneer precision RNA medicines for the heart and profoundly improve the lives of people impacted by cardiac diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Atrium Therapeutics.
91% above the average for this role
Senior Scientist II, ADC/AOC Conjugation
AbbVie
Senior Scientist I, ADC/AOC Conjugation
AbbVie
Senior Scientist II, ADC/AOC Conjugation
AbbVie
Temporary Research Associate / Scientist
iSi Environmental
Senior Scientist, Protein and Antibody Bioconjugation
lifelancer
Principal Scientist - RGM Chemistry
Regeneron Pharmaceuticals